NCT02637934View on ClinicalTrials.gov

Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

PHASE1RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 14, 2016

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Interventions
DRUG

[18F]FluorThanatrace

RADIATION

PET/CT imaging sessions

Trial Locations (1)

19104

RECRUITING

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER